IBD & The Evolution of Targeted Therapies How Far Have We Come?
Host: Ugo Iroku, MD, MHS
\n\n\n \n
This program includes updates in the management of inflammatory bowel disease (IBD), with a unique perspective on bringing light to challenges associated with patient management and their journey, and best practices on how to make appropriate interventions in a timely manner. Best practices are predicated on the latest guidelines, with a review of targeted therapies.